CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 22 enrolled
Drug / intervention
Lindioil ointment +1 moredrug
Likely dose
Lindioil ointment 200µgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03614221
NCT03614221Phase 2Completed

Comparison of the Efficacy and Safety of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® (Tacrolimus 0.1%) Ointment in Treating Atopic Dermatitis: A Randomized, Evaluator-blind, Crossover, Active-Controlled Trial

Chang Gung Memorial Hospital·interventional·Posted Aug 3, 2018·Updated Feb 10, 2023

In Brief

A Phase 2 clinical trial evaluating Lindioil ointment and Protopic ointment 0.1% for Atopic Dermatitis. Completed, enrolled 22 participants across 2 sites.

Detailed Summary

The aims of this study are: 1. Compare the efficacy of Lindioil ointment and Protopic® ointment in treating atopic dermatitis. 2. Compare the safety of Lindioil ointment and Protopic® ointment in treating atopic dermatitis. 3. Compare the time to relapse after ceasing of treatment of Lindioil ointment and Protopic® ointment. 4. Compare the change of skin microbiome before and after Lindioil ointment and Protopic® ointment treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTaiwan

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedAug 3, 2018
Enrollment StartJun 3, 2019
Primary CompletionDec 1, 2021
Study CompletionDec 6, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.9 years ago

Interventions

Lindioil ointmentdrug

Each gram contains 200µg of indirubin. Apply 0.5 g of ointment per 10 cm x 10 cm of affected skin areas twice daily for 6 weeks.

Protopic ointment 0.1%drug

Each gram contains (w/w) 0.1% of tacrolimus. Apply 0.1 g of ointment per 10 cm x 10 cm of affected skin areas twice daily for 6 weeks.